PAVmed Inc. Warrant
PAVMW
PAVMW was delisted on the 28th of January, 2022.
2 hedge funds and large institutions have $113K invested in PAVmed Inc. Warrant in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
89,583% more capital invested
Capital invested by funds: $126 → $113K (+$113K)
0% more funds holding
Funds holding: 2 → 2 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$187 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LCS
1
Levin Capital Strategies
New York
| $113K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| – | -$187 | -30 | -50% |
|
PAVMW Hedge Fund Activity: Q4 2016 in Review
2 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Warrant (PAVMW) for Q4 2016, worth a combined $113K — up 89,583% from $126 a quarter earlier.
Fund positioning in PAVMW was balanced in Q4 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $187.
- 2 institutional investors held PAVmed Inc. Warrant (PAVMW) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $113K of PAVmed Inc. Warrant stock for Q4 2016, up 89,583% quarter-over-quarter.
- 0 funds opened new PAVmed Inc. Warrant positions in Q4 2016 and 0 closed out.
- The largest PAVmed Inc. Warrant seller in Q4 2016 was UBS Group, an estimated $187 sold.
Based on aggregated 13F filings for Q4 2016.